Pharmaceuticals
Aurobindo to buy Sandoz’s dermatology business in US for $1 bn
07 Sep 2018
Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline